Novavax Aktie
WKN DE: A2PKMZ / ISIN: US6700024010
27.02.2025 14:07:10
|
Novavax Inc. Q4 Loss Drops In Line With Estimates
(RTTNews) - Novavax Inc. (NVAX) announced Loss for fourth quarter that decreased from last year in line with the Street estimates.
The company's bottom line totaled -$81.03 million, or -$0.51 per share. This compares with -$178.39 million, or -$1.44 per share, last year.
Analysts on average had expected the company to earn -$0.51 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 69.7% to $88.31 million from $291.34 million last year.
Novavax Inc. earnings at a glance (GAAP) :
-Earnings: -$81.03 Mln. vs. -$178.39 Mln. last year. -EPS: -$0.51 vs. -$1.44 last year. -Revenue: $88.31 Mln vs. $291.34 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
26.02.25 |
Ausblick: Novavax vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
11.11.24 |
Ausblick: Novavax präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) |
Analysen zu Novavax Inc.mehr Analysen
Aktien in diesem Artikel
Novavax Inc. | 5,92 | -2,05% |
|